SLC25A14 (O95258) variants and mutations
SLC25A14 (also known as O95258) is a human protein-coding gene encoding a brain mitochondrial carrier protein 1 protein. A mitochondrial carrier that transports several inorganic anions and dicarboxylates and can exchange protons across the inner membrane. Its transport and uncoupling activities help regulate mitochondrial redox balance, membrane potential, and ATP production. This analysis covers 453 SLC25A14 variants and mutations. Of these, 98% have computational variant effect predictions. Disease context includes ovarian cancer, Alzheimer disease, and neoplasm. Example SLC25A14 variants include M1?, G2S, and I3V.
Variant analysis overview
- Gene: SLC25A14
- Protein: O95258
- UniProt accession: O95258
- Organism: Homo sapiens
- Variants analyzed: 453
- Variant scope: all variants
- Completed: 2026-05-30
Variant and mutation evidence
- Variant composition: 224 unspecified-consequence records; 133 missense variants; 82 synonymous variants; 5 splice-region variants; 8 frameshift variants; 1 stop-gained variants
- Prediction scores: 444 variants have prediction scores (98% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: ovarian cancer, Alzheimer disease, neoplasm, diabetes mellitus, autism, cancer, Creutzfeldt Jacob Disease, obesity, myeloid sarcoma, type 1 diabetes mellitus, stroke, pancreatic adenocarcinoma.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments.
- Structural context: 162 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, PharmGKB, MaveDB, LitVar.
Notable SLC25A14 variants
Examples include M1?, G2S, I3V, I3S, I3I, F4L, P5P, G6R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV5441, cosmic curated COSV54417, Variant assessed as somatic; high impact.
- G2S (p.Gly2Ser), ESP rs377228654, ExAC rs377228654, TOPMed rs377228654, gnomAD rs377228654, REVEL 0.50, ESM-1b 0.00
- I3V (p.Ile3Val), gnomAD rs1435400629, REVEL 0.43, ESM-1b 0.00
- I3S (p.Ile3Ser), gnomAD X-130340286-T-G, REVEL 0.51, ESM-1b 0.00
- I3I (p.Ile3Ile), gnomAD X-130340287-C-T, CADD 15.30
- F4L (p.Phe4Leu), cosmic curated COSV54419, REVEL 0.48, ESM-1b 0.00
- P5P (p.Pro5Pro), gnomAD X-130340293-C-T, CADD 8.85
- G6R (p.Gly6Arg), NCI-TCGA TCGA novel, TOPMed rs2033203435, REVEL 0.51, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- I7V (p.Ile7Val), ExAC rs770230560, TOPMed rs770230560, gnomAD rs770230560, REVEL 0.44, ESM-1b 0.00
- I7I (p.Ile7Ile), gnomAD X-130340299-A-T, CADD 15.10
- I8N (p.Ile8Asn), gnomAD rs1372564468, REVEL 0.49, ESM-1b 0.00
- I8V (p.Ile8Val), Ensembl rs868768898, REVEL 0.34, ESM-1b 0.00
- I8I (p.Ile8Ile), rs1166070499, gnomAD X-130340302-C-A, CADD 15.10
- L9V (p.Leu9Val), ExAC rs776024974, gnomAD rs776024974, REVEL 0.37, ESM-1b 0.00
- I10F (p.Ile10Phe), NCI-TCGA Cosmic COSV5441, cosmic curated COSV54418, ESM-1b 0.00, AlphaMissense 0.11, Variant assessed as somatic; moderate impact.
- I10N (p.Ile10Asn), cosmic curated COSV10510, REVEL 0.45, ESM-1b 0.00
- I10T (p.Ile10Thr), gnomAD X-130340307-T-C, REVEL 0.40, ESM-1b 0.00
- L12L (p.Leu12Leu), rs1296782628, gnomAD X-130340312-C-T, CADD 15.00
- L12V (p.Leu12Val), gnomAD X-130340312-C-G, REVEL 0.39, ESM-1b 0.00
- R13K (p.Arg13Lys), gnomAD rs1365578901, REVEL 0.32, ESM-1b 0.00
- R13S (p.Arg13Ser), ESP rs368952448, TOPMed rs368952448, gnomAD rs368952448, REVEL 0.40, ESM-1b 0.00
- R13R (p.Arg13Arg), rs368952448, gnomAD X-130340317-G-A, CADD 15.40
- V14G (p.Val14Gly), cosmic curated COSV54419, REVEL 0.45, ESM-1b 0.00
- K15R (p.Lys15Arg), ExAC rs763208488, TOPMed rs763208488, gnomAD rs763208488, REVEL 0.37, ESM-1b 0.00
- K15E (p.Lys15Glu), gnomAD X-130340321-A-G, REVEL 0.50, ESM-1b 0.00
- F16S (p.Phe16Ser), cosmic curated COSV54417, REVEL 0.41, ESM-1b 0.00
- F16L (p.Phe16Leu), gnomAD X-130340324-T-C, REVEL 0.37, ESM-1b 0.00
- A17V (p.Ala17Val), NCI-TCGA Cosmic COSV9950, cosmic curated COSV99502, REVEL 0.40, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- T18M (p.Thr18Met), ESP rs371552768, REVEL 0.46, ESM-1b 0.00
- T18T (p.Thr18Thr), rs150106204, gnomAD X-130340332-G-A, CADD 14.60
- A19T (p.Ala19Thr), Ensembl rs12833635, REVEL 0.42, ESM-1b 0.00
- A19V (p.Ala19Val), TOPMed rs1370693804, gnomAD rs1370693804, REVEL 0.40, ESM-1b 0.00
- A20S (p.Ala20Ser), gnomAD X-130340336-G-T, REVEL 0.38, ESM-1b 0.00
- A20A (p.Ala20Ala), rs1379960873, gnomAD X-130340338-C-G, CADD 8.76
- V21L (p.Val21Leu), TOPMed rs1166382619, REVEL 0.36, ESM-1b 0.00
- V21M (p.Val21Met), NCI-TCGA Cosmic COSV5442, cosmic curated COSV54420, REVEL 0.35, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- I22S (p.Ile22Ser), gnomAD X-130340343-T-G, REVEL 0.36, ESM-1b 0.00
- S24S (p.Ser24Ser), gnomAD X-130340350-C-T, CADD 19.60
- G25=, NCI-TCGA Cosmic COSV9950, Variant assessed as somatic; low impact.
- G25V (p.Gly25Val), NCI-TCGA Cosmic COSV5442, cosmic curated COSV54420, REVEL 0.38, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- H26Y (p.His26Tyr), Ensembl rs1338622117, REVEL 0.14, ESM-1b 0.00
- H26N (p.His26Asn), gnomAD X-130345182-C-A, REVEL 0.14, ESM-1b 0.00
- H26R (p.His26Arg), gnomAD X-130345183-A-G, REVEL 0.23, ESM-1b 0.00
- H26H (p.His26His), gnomAD X-130345184-C-T, CADD 14.30
- H26Q (p.His26Gln), gnomAD X-130345184-C-A, REVEL 0.16, ESM-1b 0.00
- Q27K (p.Gln27Lys), NCI-TCGA Cosmic COSV5441, cosmic curated COSV54419, REVEL 0.31, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- Q27L (p.Gln27Leu), cosmic curated COSV99502, REVEL 0.41, ESM-1b 0.00
- K28R (p.Lys28Arg), cosmic curated COSV54418, REVEL 0.10, ESM-1b 0.00
- K28E (p.Lys28Glu), gnomAD X-130345188-A-G, REVEL 0.20, ESM-1b 0.00
- S29N (p.Ser29Asn), NCI-TCGA Cosmic COSV5442, cosmic curated COSV54420, REVEL 0.20, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- S29G (p.Ser29Gly), gnomAD X-130345191-A-G, REVEL 0.16, ESM-1b 0.00
- T30A (p.Thr30Ala), gnomAD rs1326949180, REVEL 0.28, ESM-1b 0.00
- T30S (p.Thr30Ser), gnomAD X-130345194-A-T, REVEL 0.26, ESM-1b 0.00
- T30I (p.Thr30Ile), gnomAD X-130345195-C-T, REVEL 0.14, ESM-1b 0.00
- T30N (p.Thr30Asn), gnomAD X-130345195-C-A, REVEL 0.18, ESM-1b 0.00
- T30T (p.Thr30Thr), gnomAD X-130345196-C-T, CADD 10.20
- T31I (p.Thr31Ile), cosmic curated COSV10587, REVEL 0.29, ESM-1b 0.00
- T31N (p.Thr31Asn), TOPMed rs1320415340, gnomAD rs1320415340, REVEL 0.13, ESM-1b 0.00
- T31T (p.Thr31Thr), gnomAD X-130345199-T-C, CADD 10.90
- V32I (p.Val32Ile), gnomAD X-130345200-G-A, REVEL 0.14, ESM-1b 0.00
- V32V (p.Val32Val), gnomAD X-130345202-A-G, CADD 11.10
- S33N (p.Ser33Asn), gnomAD X-130345204-G-A, REVEL 0.21, ESM-1b 0.00
- H34L (p.His34Leu), TOPMed rs2033392342, REVEL 0.25, ESM-1b 0.00
- H34R (p.His34Arg), TOPMed rs2033392342, REVEL 0.19, ESM-1b 0.00
- H34M (p.His34Met), rs1457818921, gnomAD X-130345205-TC-T, CADD 26.30
- H34N (p.His34Asn), gnomAD X-130345206-C-A, REVEL 0.14, ESM-1b 0.00
- H34Q (p.His34Gln), gnomAD X-130345208-T-G, REVEL 0.21, ESM-1b 0.00
- E35* (p.Glu35Ter), NCI-TCGA Cosmic COSV5442, cosmic curated COSV54420, Variant assessed as somatic; high impact.
- E35K (p.Glu35Lys), gnomAD rs1341424045, REVEL 0.30, ESM-1b 0.00
- S37S (p.Ser37Ser), rs778640263, gnomAD X-130345217-T-G, CADD 13.00
- G38V (p.Gly38Val), NCI-TCGA TCGA novel, REVEL 0.34, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- G38D (p.Gly38Asp), gnomAD X-130345219-G-A, REVEL 0.32, ESM-1b 0.00
- L39M (p.Leu39Met), cosmic curated COSV54419, REVEL 0.27, ESM-1b 0.00
- L39V (p.Leu39Val), ExAC rs752483493, gnomAD rs752483493, REVEL 0.29, ESM-1b 1.00
- L39L (p.Leu39Leu), gnomAD X-130345223-G-C, CADD 10.00
- N40S (p.Asn40Ser), TOPMed rs1387943746, REVEL 0.21, ESM-1b 0.84
- N40N (p.Asn40Asn), rs1378203322, gnomAD X-130345226-T-C, CADD 7.73
- P43P (p.Pro43Pro), rs1227918119, gnomAD X-130345235-C-T, CADD 11.90
- V45I (p.Val45Ile), gnomAD X-130345239-G-A, REVEL 0.18, ESM-1b 0.00
- V45V (p.Val45Val), gnomAD X-130345241-A-G, CADD 6.98
- Y46Y (p.Tyr46Tyr), rs1157259841, gnomAD X-130345244-T-C, CADD 10.70
- G47G (p.Gly47Gly), rs758053843, gnomAD X-130345247-C-T, CADD 13.30
- G48S (p.Gly48Ser), NCI-TCGA Cosmic COSV9950, cosmic curated COSV99502, REVEL 0.78, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- G48D (p.Gly48Asp), gnomAD X-130345249-G-A, REVEL 0.93, ESM-1b 1.00
- L49F (p.Leu49Phe), Ensembl rs2124745987, REVEL 0.49, ESM-1b 0.32
- L49R (p.Leu49Arg), gnomAD X-130345252-T-G, REVEL 0.88, ESM-1b 1.00
- A50D (p.Ala50Asp), gnomAD X-130345255-C-A, REVEL 0.93, ESM-1b 1.00
- A50A (p.Ala50Ala), gnomAD X-130345256-C-A, CADD 11.80
- S51L (p.Ser51Leu), gnomAD X-130345254-GC-G, CADD 26.80
- S51A (p.Ser51Ala), gnomAD X-130345257-T-G, REVEL 0.58, ESM-1b 1.00
- S51P (p.Ser51Pro), gnomAD X-130345257-T-C, REVEL 0.87, ESM-1b 1.00
- S51Y (p.Ser51Tyr), gnomAD X-130345258-C-A, REVEL 0.89, ESM-1b 1.00
- S51C (p.Ser51Cys), gnomAD X-130345258-C-G, REVEL 0.65, ESM-1b 1.00
- S51S (p.Ser51Ser), gnomAD X-130345259-T-C, CADD 12.40
- I52T (p.Ile52Thr), TOPMed rs1163024491, gnomAD rs1163024491, REVEL 0.53, ESM-1b 1.00
- I52V (p.Ile52Val), gnomAD X-130345260-A-G, REVEL 0.23, ESM-1b 1.00
- I52I (p.Ile52Ile), rs145571486, gnomAD X-130345262-C-A, CADD 9.80
- V53M (p.Val53Met), 1000Genomes rs377260983, ESP rs377260983, ExAC rs377260983, TOPMed rs377260983, REVEL 0.41, ESM-1b 0.00
- A54T (p.Ala54Thr), gnomAD X-130345266-G-A, REVEL 0.83, ESM-1b 1.00
- A54D (p.Ala54Asp), gnomAD X-130345267-C-A, REVEL 0.91, ESM-1b 1.00
- A54V (p.Ala54Val), gnomAD X-130345267-C-T, REVEL 0.84, ESM-1b 1.00
- A54A (p.Ala54Ala), gnomAD X-130345268-T-C, CADD 8.60
- E55A (p.Glu55Ala), rs2143598, UniProt VAR 050138, TOPMed rs2143598, ESM-1b 0.91, AlphaMissense 0.95
- E55G (p.Glu55Gly), TOPMed rs2143598, REVEL 0.67, ESM-1b 0.00
- E55K (p.Glu55Lys), gnomAD X-130345269-G-A, REVEL 0.66, ESM-1b 1.00
- E55E (p.Glu55Glu), rs1448054403, gnomAD X-130345271-G-A, CADD 8.03
- F56L (p.Phe56Leu), gnomAD X-130345272-T-C, REVEL 0.36, ESM-1b 0.07
- G57R (p.Gly57Arg), gnomAD X-130345275-G-A, REVEL 0.80, ESM-1b 1.00
- T58P (p.Thr58Pro), Ensembl rs2033446489, REVEL 0.96, ESM-1b 1.00
- T58A (p.Thr58Ala), gnomAD X-130346546-A-G, REVEL 0.88, ESM-1b 1.00
- P60L (p.Pro60Leu), NCI-TCGA Cosmic COSV5442, cosmic curated COSV54420, ESM-1b 1.00, AlphaMissense 0.99, Variant assessed as somatic; moderate impact.
- P60T (p.Pro60Thr), cosmic curated COSV54417, REVEL 0.95, ESM-1b 1.00
- V61A (p.Val61Ala), TOPMed rs1184553883, REVEL 0.64, ESM-1b 1.00
- V61M (p.Val61Met), gnomAD X-130346555-G-A, REVEL 0.33, ESM-1b 1.00
- L63L (p.Leu63Leu), rs1473141701, gnomAD X-130346563-T-C, CADD 5.91
- T64T (p.Thr64Thr), gnomAD X-130346566-C-A, CADD 7.08
- T66T (p.Thr66Thr), gnomAD X-130346572-A-T, CADD 3.31
- R67* (p.Arg67Ter), NCI-TCGA TCGA novel, TOPMed rs2033447213, CADD 34.00, Variant assessed as somatic; high impact.
- R67Q (p.Arg67Gln), NCI-TCGA Cosmic COSV9950, cosmic curated COSV99502, REVEL 0.89, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- R67G (p.Arg67Gly), gnomAD X-130346573-C-G, REVEL 0.89, ESM-1b 1.00
- R67L (p.Arg67Leu), gnomAD X-130346574-G-T, REVEL 0.90, ESM-1b 1.00
- Q69* (p.Gln69Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q69R (p.Gln69Arg), gnomAD X-130346580-A-G, REVEL 0.94, ESM-1b 1.00
- V70I (p.Val70Ile), NCI-TCGA Cosmic COSV5441, cosmic curated COSV54419, REVEL 0.35, ESM-1b 0.50, Variant assessed as somatic; moderate impact.
- V70V (p.Val70Val), rs1442403476, gnomAD X-130346584-T-G, CADD 7.74
- G72D (p.Gly72Asp), NCI-TCGA Cosmic COSV9950, cosmic curated COSV99502, REVEL 0.88, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- Q73R (p.Gln73Arg), gnomAD X-130346592-A-G, REVEL 0.75, ESM-1b 1.00
- S74R (p.Ser74Arg), TOPMed rs2033447715, REVEL 0.24, ESM-1b 1.00
- S74C (p.Ser74Cys), gnomAD X-130346594-A-T, REVEL 0.45, ESM-1b 1.00
- I75N (p.Ile75Asn), TOPMed rs1212037064, gnomAD rs1212037064, REVEL 0.17, ESM-1b 1.00
- I75T (p.Ile75Thr), TOPMed rs1212037064, gnomAD rs1212037064, REVEL 0.23, ESM-1b 1.00
- D76A (p.Asp76Ala), NCI-TCGA Cosmic COSV5441, cosmic curated COSV54419, REVEL 0.51, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- A77T (p.Ala77Thr), 1000Genomes rs748623528, ExAC rs748623528, TOPMed rs748623528, gnomAD rs748623528, REVEL 0.28, ESM-1b 0.00
- A77D (p.Ala77Asp), gnomAD X-130346604-C-A, REVEL 0.17, ESM-1b 1.00
- R78C (p.Arg78Cys), TOPMed rs1004559926, REVEL 0.36, ESM-1b 1.00
- R78H (p.Arg78His), cosmic curated COSV54419, TOPMed rs1011354966, gnomAD rs1011354966, REVEL 0.28, ESM-1b 0.48
- R78G (p.Arg78Gly), gnomAD X-130346606-C-G, REVEL 0.30, ESM-1b 1.00
- F79F (p.Phe79Phe), rs756996672, gnomAD X-130346611-C-T, CADD 9.84
- K80K (p.Lys80Lys), gnomAD X-130346614-A-G, CADD 11.00
- E81E (p.Glu81Glu), rs148888253, gnomAD X-130346617-G-A, CADD 7.95
- I82R (p.Ile82Arg), gnomAD X-130346619-T-G, REVEL 0.59, ESM-1b 1.00
- Y84C (p.Tyr84Cys), gnomAD X-130346625-A-G, REVEL 0.95, ESM-1b 1.00
- Y84Y (p.Tyr84Tyr), rs201214496, gnomAD X-130346626-T-C, CADD 8.26
- R85R (p.Arg85Arg), rs756679763, gnomAD X-130346629-A-G, CADD 13.30
- G86W (p.Gly86Trp), cosmic curated COSV99502, REVEL 0.97, ESM-1b 1.00
- G86G (p.Gly86Gly), gnomAD X-130346632-G-A, CADD 8.24
- M87T (p.Met87Thr), cosmic curated COSV10587, REVEL 0.78, ESM-1b 1.00
- F88C (p.Phe88Cys), NCI-TCGA Cosmic COSV9950, cosmic curated COSV99502, REVEL 0.74, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- F88F (p.Phe88Phe), gnomAD X-130346638-C-T, CADD 7.74
- H89Y (p.His89Tyr), NCI-TCGA Cosmic COSV9950, cosmic curated COSV99502, REVEL 0.73, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- H89H (p.His89His), gnomAD X-130346641-T-C, CADD 6.92
- A90T (p.Ala90Thr), ExAC rs780494499, gnomAD rs780494499, REVEL 0.63, ESM-1b 1.00
- A90V (p.Ala90Val), cosmic curated COSV10804, ExAC rs749809718, gnomAD rs749809718, REVEL 0.71, ESM-1b 1.00
- A90E (p.Ala90Glu), gnomAD X-130346643-C-A, REVEL 0.87, ESM-1b 1.00
- A90A (p.Ala90Ala), rs772442657, gnomAD X-130346644-G-A, CADD 5.21
- L91M (p.Leu91Met), gnomAD X-130346645-C-A, REVEL 0.43, ESM-1b 0.00
- F92F (p.Phe92Phe), rs774803188, gnomAD X-130346650-T-C, CADD 8.35
- R93C (p.Arg93Cys), rs143550393, NCI-TCGA Cosmic COSV5441, cosmic curated COSV54418, ESP rs143550393, REVEL 0.69, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- R93H (p.Arg93His), NCI-TCGA Cosmic COSV5441, cosmic curated COSV54417, REVEL 0.71, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- R93R (p.Arg93Arg), gnomAD X-130346653-C-A, CADD 6.06
- C95Y (p.Cys95Tyr), TOPMed rs1229803745, gnomAD rs1229803745, REVEL 0.34, ESM-1b 0.00
- E98E (p.Glu98Glu), rs1408182165, gnomAD X-130346668-A-G, CADD 11.00
- V100A (p.Val100Ala), Ensembl rs2124747814, REVEL 0.47, ESM-1b 0.00
- L101S (p.Leu101Ser), ExAC rs772321835, gnomAD rs772321835, ESM-1b 1.00, AlphaMissense 0.16
- L101L (p.Leu101Leu), gnomAD X-130346677-G-A, CADD 9.44
- A102T (p.Ala102Thr), cosmic curated COSV54419, REVEL 0.82, ESM-1b 1.00
- A102V (p.Ala102Val), gnomAD X-130346679-C-T, REVEL 0.88, ESM-1b 1.00
- A102D (p.Ala102Asp), gnomAD X-130346679-C-A, REVEL 0.89, ESM-1b 1.00
- A102A (p.Ala102Ala), gnomAD X-130346680-T-G, CADD 7.84
- L103F (p.Leu103Phe), gnomAD X-130346681-C-T, REVEL 0.65, ESM-1b 1.00
- L103L (p.Leu103Leu), rs1336363100, gnomAD X-130346683-C-T, CADD 3.47
- Y104F (p.Tyr104Phe), NCI-TCGA Cosmic COSV5441, cosmic curated COSV54418, REVEL 0.71, ESM-1b 1.00, Variant assessed as somatic; moderate impact.
- Y104C (p.Tyr104Cys), gnomAD X-130346685-A-G, REVEL 0.93, ESM-1b 1.00
- S105* (p.Ser105Ter), cosmic curated COSV54420, CADD 35.00
- G106G (p.Gly106Gly), gnomAD X-130349251-A-T, CADD 12.20
- I107T (p.Ile107Thr), Ensembl rs934114863, REVEL 0.81, ESM-1b 1.00
- I107V (p.Ile107Val), gnomAD X-130349252-A-G, REVEL 0.38, ESM-1b 0.57
- I107F (p.Ile107Phe), gnomAD X-130349252-A-T, REVEL 0.76, ESM-1b 1.00
- I107N (p.Ile107Asn), gnomAD X-130349253-T-A, REVEL 0.79, ESM-1b 1.00
- I107I (p.Ile107Ile), gnomAD X-130349254-T-C, CADD 4.85
Public SLC25A14 analysis runs
- SLC25A14 analysis run — SLC25A14 (453 variants) — completed 2026-05-30